Constituït a la tardor del 2011 i format pels següents 10 experts de reconegut prestigi en el camp de l’oncologia, el Consell Científic Assessor del VHIO ajudarà sens dubte que el VHIO continuï duent a terme la seva missió de desenvolupar i promoure una investigació translacional d’excel·lència:
Carlos L. Arteaga, MD (Chair)
- Donna S. Hall Chair in Breast Cancer
- Professor of Medicine and Cancer Biology
- Associate Director of Clinical Research, Vanderbilt-Ingram Cancer Center, Nashville, USA
René Bernards, PhD
- Head of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Julio E. Celis, PhD
- Scientific Director, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark
Andrés Cervantes, MD, PhD
- Associate Professor of Medicine, Head of Section of the Hematology and Medical Oncology Department, University Hospital of Valencia, Valencia, Spain
Fortunato Ciardiello, MD, PhD
- Full Professor of Medical Oncology, Head of Experimental Therapeutics, the Division of Medical Oncology, Seconda Universitá di Napoli, Naples, Italy.
Stanley B. Kaye, MD, FRCP, FRCR
- Head of the Drug Development Unit and Head of the Section of Medicine, The Royal Marsden Hospital and The Institute of Cancer Research, London, UK
Carlos López Otín, PhD
- Professor, Department of Biochemistry and Molecular Biology, University of Oviedo, Spain
Richard Marais, PhD
- Director, Paterson Institute for Cancer Research, Manchester, UK
Jorge Reis-Filho, MD, PhD
- Physician-Scientist and Lab Leader, Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, USA
Jesús San Miguel Izquierdo, MD
- Scientific Director, Salamanca Institute of Biomedical Research, Salamanca, Spain